Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluid therapy during therapeutic hypothermia after cardiac arrest
2005-005111-24Phase 4Completed
- Sponsor
- Haukeland University Hospital
- Start
- Nov 2005
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of HyperHAES and ringer's acetate in cardiac arrest (SCA) (2 arms), sponsored by Haukeland University Hospital. Primary endpoints: Death and survival rate and Cognitive score at 12 months. Started Nov 2005; status: completed.
02
Drugs
HyperHAESringer's acetate
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2005-005111-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005111-24.